Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, April 19 '25)

Image
By G.M.

 


    Am J Med

  1. BILC M, Cramer H
    Use of Complementary Medicine Among US Adults with Post-COVID-19: Results from the 2022 National Health Interview Survey.
    Am J Med. 2025;138:862-869.
    PubMed         Abstract available

  2. MAURO M, Cegolon L, Bestiaco N, Zulian E, et al
    Heart Rate Variability Modulation Through Slow-Paced Breathing in Health Care Workers with Long COVID: A Case-Control Study.
    Am J Med. 2025;138:870-883.
    PubMed         Abstract available

  3. NAIK H, Wilton J, Tran KC, Janjua NZ, et al
    Long-Term Health-Related Quality of Life in Working-Age COVID-19 Survivors: A Cross-Sectional Study.
    Am J Med. 2025;138:850-861.
    PubMed         Abstract available

  4. PALACIO A, Bast E, Klimas N, Tamariz L, et al
    Lessons Learned in Implementing a Multidisciplinary Long COVID Clinic.
    Am J Med. 2025;138:843-849.
    PubMed         Abstract available

  5. KRUMHOLZ HM, Sawano M, Bhattacharjee B, Caraballo C, et al
    The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID.
    Am J Med. 2024 May 10:S0002-9343(24)00271-7. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available

  6. SANAL-HAYES NEM, Hayes LD, Mclaughlin M, Berry ECJ, et al
    People with Long COVID and ME/CFS Exhibit Similarly Impaired Dexterity and Bimanual Coordination: A Case-Case-Control Study.
    Am J Med. 2025;138:893-900.
    PubMed         Abstract available


    BMC Pediatr

  7. SINAEI R, Hosseininasab A, Abbaslou P, Zeinali M, et al
    Gastrointestinal and hepatic manifestations among hospitalized COVID-19 children.
    BMC Pediatr. 2025;25:308.
    PubMed         Abstract available


    Epidemiol Infect

  8. ABUCAR EAM, Kern M, Kurth T, Meierkord A, et al
    Health-related quality of life up to 2 years after SARS-CoV-2 infection: a descriptive cohort study.
    Epidemiol Infect. 2025;153:e60.
    PubMed         Abstract available


    J Exp Med

  9. SAIDOUNE F, Lee D, Di Domizio J, Le Floc'h C, et al
    Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains.
    J Exp Med. 2025;222:e20231467.
    PubMed         Abstract available


    J Immunol

  10. MADRID DMC, Gu W, Karim SJI, Lowke MT, et al
    Single-cell analysis of pig lung leukocytes and their response to influenza infection and oseltamivir therapy.
    J Immunol. 2025 Apr 15:vkaf032. doi: 10.1093.
    PubMed         Abstract available


    J Infect Dis

  11. MORRIS SE, Mathis SM, Reeves E, Chung JR, et al
    Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States.
    J Infect Dis. 2025 Apr 12:jiaf061. doi: 10.1093.
    PubMed         Abstract available

  12. CORTIER T, Gilboa M, Layan M, Joseph G, et al
    Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS).
    J Infect Dis. 2025;231:e734-e742.
    PubMed         Abstract available

  13. KOZANLI E, Winkel AMAM, Han AX, van den Brink S, et al
    Shortened SARS-CoV-2 Viral RNA Shedding in Saliva During Early Omicron Compared to Wild-Type Pandemic Phase.
    J Infect Dis. 2025;231:940-945.
    PubMed         Abstract available

  14. CHALKIAS S, Pragalos A, Akinsola A, Berman G, et al
    Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain andN-Terminal Domain mRNA Vaccine.
    J Infect Dis. 2025 Jan 10:jiaf022. doi: 10.1093.
    PubMed         Abstract available

  15. FELDSTEIN LR, Ruffin J, Wiegand RE, Borkowf CB, et al
    Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States.
    J Infect Dis. 2025 Jan 8:jiaf007. doi: 10.1093.
    PubMed         Abstract available

  16. DOLANGE V, Slamanig S, Abdeljawad A, Lai TY, et al
    A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
    J Infect Dis. 2025;231:e723-e733.
    PubMed         Abstract available

  17. ALESSANDRINI J, Smith BT, Fitzpatrick T, Buchan SA, et al
    Socioeconomic Inequities in the Age-Specific Burden of Severe Respiratory Syncytial Virus in Canada, 2016-2019.
    J Infect Dis. 2025;231:e626-e637.
    PubMed         Abstract available

  18. JACOBS MB, Clark AE, Goldhaber NH, Valentine HD, et al
    Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays Correlate With COVID-19 Infection Risk in a Large Population.
    J Infect Dis. 2025;231:921-930.
    PubMed         Abstract available

  19. SANKARANARAYANAN R, Ha B, Sun H, Liu K, et al
    Evaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory Syncytial Virus Infection in Infants and Young Children.
    J Infect Dis. 2025;231:1060-1068.
    PubMed         Abstract available

  20. CHO HK, Frivold C, Chu HY
    Maternal Immunization.
    J Infect Dis. 2025;231:830-836.
    PubMed         Abstract available


    J Virol

  21. HU H, Zhang Y, Zheng H, Zhao X, et al
    Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response.
    J Virol. 2025 Mar 4:e0232324. doi: 10.1128/jvi.02323.
    PubMed         Abstract available

  22. KARL V, Hofmann M, Thimme R
    Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination.
    J Virol. 2025 Mar 3:e0135024. doi: 10.1128/jvi.01350.
    PubMed         Abstract available

  23. LOWEN AC, Baker AL, Bowman AS, Garcia-Sastre A, et al
    Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns.
    J Virol. 2025;99:e0005225.
    PubMed         Abstract available

  24. SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al
    SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
    J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077.
    PubMed         Abstract available

  25. DADONAITE B, Burrell AR, Logue J, Chu HY, et al
    SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.
    J Virol. 2025 Mar 25:e0010925. doi: 10.1128/jvi.00109.
    PubMed         Abstract available

  26. JOHN K, Huntress I, Smith E, Chou H, et al
    Human long noncoding RNA VILMIR is induced by major respiratory viral infections and modulates the host interferon response.
    J Virol. 2025 Mar 25:e0014125. doi: 10.1128/jvi.00141.
    PubMed         Abstract available

  27. LI P, Faraone JN, Hsu CC, Chamblee M, et al
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.
    J Virol. 2025 Mar 26:e0024225. doi: 10.1128/jvi.00242.
    PubMed         Abstract available

  28. JANA ID, Kanjo K, Roy S, Bhasin M, et al
    Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants.
    J Virol. 2025 Mar 26:e0005125. doi: 10.1128/jvi.00051.
    PubMed         Abstract available


    J Virol Methods

  29. CHANG C, Li L, Guo Y, Ji L, et al
    The potential application of digital PCR in detecting different SARS-CoV-2 viral loads.
    J Virol Methods. 2025;335:115151.
    PubMed         Abstract available

  30. DE BEER C, Vanmali HD
    Genotypic analysis of rhinovirus and human respiratory syncytial virus in sudden unexpected death in infancy cases at Tygerberg Hospital, Cape Town, South Africa.
    J Virol Methods. 2025;335:115150.
    PubMed         Abstract available

  31. ZARGAR B, Sattar SA, McKinney J, Ijaz MK, et al
    The stability and elimination of mammalian enveloped and non-enveloped respiratory and enteric viruses in indoor air: Testing using a room-sized aerobiology chamber.
    J Virol Methods. 2025;335:115144.
    PubMed         Abstract available

  32. REYNA RA, Walker J, Viveros A, Mitchell B, et al
    Optimization of a panel of behavioral tests for use in containment using a golden Syrian hamster model.
    J Virol Methods. 2025;335:115132.
    PubMed         Abstract available


    Minerva Pediatr (Torino)

  33. PECORARO L, Castagnoli R, Salemi C, Piacentini G, et al
    The "stay at home" COVID-19 lockdown restriction may have prevented asthma exacerbations in children affected by pollen allergy: a single center experience.
    Minerva Pediatr (Torino). 2025;77:139-142.
    PubMed         Abstract available

  34. SODERO G, Talloa D, Cipolla C
    GH therapy in children and adolescents with growth hormone deficiency during the first phase of COVID-19 lockdown: a survey in an Italian center.
    Minerva Pediatr (Torino). 2025;77:148-153.
    PubMed         Abstract available

  35. TESARI CRNKOVIC H, Bendelja K, Gjergja Juraski R, Turkalj M, et al
    Respiratory syncytial virus specific immunoglobulin G4 antibodies and atopic diseases in children.
    Minerva Pediatr (Torino). 2025;77:130-138.
    PubMed         Abstract available


    PLoS Comput Biol

  36. POZZATI G, Flores SC
    Combining flipped-classroom and spaced-repetition learning in a master-level bioinformatics course.
    PLoS Comput Biol. 2025;21:e1012863.
    PubMed         Abstract available


    PLoS One

  37. IWU CD, Shrestha P, Littman AJ, Hood JE, et al
    The association between healthcare access and shingles vaccination among older adults in Virginia, United States.
    PLoS One. 2025;20:e0316429.
    PubMed         Abstract available

  38. STRICKLING M, Zarif N, Nguyen H, Moradi Khalaj S, et al
    A comparison of fit, heat stress, oxygen saturation and comfort between a novel reusable mask and disposable N95 respirator.
    PLoS One. 2025;20:e0321538.
    PubMed         Abstract available

  39. AGUIRRE-MILACHAY E, Leon-Figueroa DA, Diaz-Velez C, Valladares-Garrido MJ, et al
    Factors associated with the survival of adults with COVID-19 using a high-flow nasal cannula in a tertiary hospital in northern Peru during the second wave of the pandemic.
    PLoS One. 2025;20:e0309855.
    PubMed         Abstract available

  40. VILLOTA SD, Veloz-Villavicencio E, Garcia-Iturralde S, Arevalo JV, et al
    Validation of new equipment for SARS-CoV-2 diagnosis in Ecuador: Detection of the virus and antibodies generated by disease and vaccines with one POC device.
    PLoS One. 2025;20:e0321794.
    PubMed         Abstract available

  41. PARKINSON C, Shen X, MacDonald M, Logan SW, et al
    Outdoor recreation's association with mental health and well-being during the COVID-19 pandemic.
    PLoS One. 2025;20:e0321278.
    PubMed         Abstract available

  42. SUSLOW A, Schlossler K, Chikhradze N, Lauer R, et al
    Should I stay or should I go-Medical assistants experiences and coping with patient demand and lack of appreciation during the Covid-19 pandemic.
    PLoS One. 2025;20:e0320953.
    PubMed         Abstract available

  43. LEISER R, McLeod J, Mapp F, Stirrup O, et al
    Insights into the implementation of a whole genome sequencing report form (SRF) to reduce nosocomial SARS-CoV-2 in UK hospitals within an unfolding pandemic: A qualitative process evaluation using normalisation process theory.
    PLoS One. 2025;20:e0321534.
    PubMed         Abstract available

  44. CILOVIC-LAGARIJA S, Eitze S, Skocibusic S, Musa S, et al
    Behavioral insights during the COVID-19 pandemic in the Federation of Bosnia and Herzegovina: the role of trust, health literacy, risk and fairness perceptions in compliance with public health and social measures.
    PLoS One. 2025;20:e0320433.
    PubMed         Abstract available

  45. QUINTERO-RINCON A, Di-Pasquale R, Quintero-Rodriguez K, Batatia H, et al
    Computer-based quantitative image texture analysis using multi-collinearity diagnosis in chest X-ray images.
    PLoS One. 2025;20:e0320706.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  46. RIOS CARRASCO M, Lin TH, Zhu X, Gabarroca Garcia A, et al
    The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
    Proc Natl Acad Sci U S A. 2025;122:e2419800122.
    PubMed         Abstract available

  47. HUANG QJ, Kim R, Song K, Grigorieff N, et al
    Virion-associated influenza hemagglutinin clusters upon sialic acid binding visualized by cryoelectron tomography.
    Proc Natl Acad Sci U S A. 2025;122:e2426427122.
    PubMed         Abstract available


    Vaccine

  48. TONG F, Zhou T, Tang L, Wu X, et al
    Evaluating the impact of influenza vaccine on preventing stroke hospitalization and death in Chinese elderly hypertensive patients: A retrospective cohort study.
    Vaccine. 2025;54:127004.
    PubMed         Abstract available


    Virology

  49. BEAUDOIN-BUSSIERES G, Tauzin A, Dionne K, El Ferri O, et al
    Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1.
    Virology. 2025;607:110512.
    PubMed         Abstract available

  50. ANDERSON M, Lopez J, Wyr M, Ramirez PW, et al
    Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities.
    Virology. 2025;607:110507.
    PubMed         Abstract available

  51. CHAKRABORTY C, Bhattacharya M, Abdelhameed AS
    Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron's several subvariants and the current rise of KP.3.1.1 and XEC.
    Virology. 2025;607:110508.
    PubMed         Abstract available


    Virus Res

  52. ZHAO X, Zhu X, Wang J, Ye C, et al
    The epidemiological analysis of respiratory virus infections in Children in Hangzhou from 2019 to 2023.
    Virus Res. 2025;355:199558.
    PubMed         Abstract available

  53. ZADEH VR, Lew JM, Zahoor MA, Santer D, et al
    Combination therapy enhances the antiviral activity of IFN-lambda against SARS-CoV-2 and MERS-CoV.
    Virus Res. 2025;355:199560.
    PubMed         Abstract available

  54. YAN J, Liu F, Hu S, Pan J, et al
    Regional dynamics and mechanisms behind SARS-CoV-2 XDV.1 prevalence in Chongqing via genomic surveillance and molecular insights.
    Virus Res. 2025;355:199562.
    PubMed         Abstract available

  55. YANG W, Tao T, Zhang J, Yao Y, et al
    The association of cycle threshold value with clinical features in patients infected with Omicron variant.
    Virus Res. 2025;355:199565.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »